Pluristem Therapeutics to Present to President Bush and Others at the First Annual Israeli Presidential Conference

NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NASDAQ:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, announced today that it has been chosen to present at the First Annual Israeli Presidential Conference termed “Facing Tomorrow", to be held on May 13-15, 2008 in Jerusalem.